Stock listing

Frankfurt:82C NIOX Group PLC Aktie

German listing (Frankfurt) of NIOX Group PLC · home listing LSE:NIOX

Follow NIOX Group PLC into a list and get an email when it puts out news.

Share price · FWB:82C

€0.685 EUR +0.005 (+0.7%)

Close on Nov 20, 2026

Past year +1.2% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.680 – €0.690 EURNov 20, 2026
Market cap
€288.3M EURAt the close on Nov 20, 2026 · price × 420.9M shares outstanding
52-week range
€0.600 – €0.837 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€1,047 EURMedian day 0 shares · 49 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
NIOX Group PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:NIOX · Home60.00p GBX (pence)-1.00 (-1.6%)2,028,36859.12p62.80p59.12p61.00pClose on Nov 20, 2026
Frankfurt:82C€0.685 EUR+0.005 (+0.7%)—€0.685€0.690€0.680€0.680Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:82C · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.740+0.003+0.4%€0.723€0.747€0.7200
€0.737-0.005-0.7%€0.747€0.753€0.7130
€0.742-0.004-0.5%€0.750€0.755€0.7410
€0.746-0.020-2.6%€0.775€0.779€0.7440
€0.766-0.015-1.9%€0.776€0.776€0.7630
€0.781-0.002-0.3%€0.797€0.800€0.774206
€0.783-0.004-0.5%€0.780€0.795€0.7721,176
€0.787+0.001+0.1%€0.790€0.790€0.7871,176
€0.786+0.018+2.3%€0.772€0.790€0.7720
€0.768-0.009-1.2%€0.783€0.790€0.7580
€0.777+0.005+0.6%€0.778€0.779€0.7770
€0.772+0.015+2.0%€0.767€0.786€0.7610
€0.757-0.024-3.1%€0.794€0.794€0.7540
€0.781-0.001-0.1%€0.783€0.783€0.7680
€0.782+0.005+0.6%€0.787€0.790€0.7680
€0.777+0.005+0.6%€0.778€0.778€0.7750
€0.772+0.002+0.3%€0.778€0.778€0.7670
€0.770-0.014-1.8%€0.771€0.784€0.7690
€0.784+0.011+1.4%€0.787€0.796€0.7760
€0.773+0.013+1.7%€0.765€0.837€0.7521,200
€0.760-0.003-0.4%€0.777€0.790€0.75912,700
€0.763+0.001+0.1%€0.761€0.763€0.76154,000
€0.762-0.001-0.1%€0.773€0.776€0.7620
€0.763+0.004+0.5%€0.766€0.771€0.7630
€0.759-0.001-0.1%€0.759€0.759€0.7590
€0.760+0.013+1.7%€0.750€0.764€0.7480
€0.747+0.001+0.1%€0.777€0.796€0.7410
€0.746+0.004+0.5%€0.758€0.766€0.7440
€0.742+0.011+1.5%€0.742€0.742€0.7420
€0.731+0.007+1.0%€0.736€0.740€0.7280
€0.724-0.032-4.2%€0.756€0.763€0.7240
€0.756+0.003+0.4%€0.758€0.759€0.7490
€0.753+0.001+0.1%€0.760€0.763€0.7510
€0.752+0.007+0.9%€0.762€0.766€0.7504,894
€0.745-0.011-1.5%€0.750€0.761€0.7380
€0.756+0.018+2.4%€0.747€0.760€0.7450
€0.738+0.003+0.4%€0.741€0.755€0.7290
€0.735-0.003-0.4%€0.738€0.744€0.7340
€0.738+0.006+0.8%€0.738€0.752€0.7370
€0.732-0.003-0.4%€0.740€0.817€0.7293,000
€0.735+0.011+1.5%€0.731€0.736€0.7260
€0.724-0.008-1.1%€0.735€0.754€0.7180
€0.732-0.024-3.2%€0.744€0.748€0.7260
€0.756+0.002+0.3%€0.764€0.768€0.7560
€0.754+0.003+0.4%€0.759€0.775€0.7490
€0.751-0.003-0.4%€0.757€0.771€0.7440
€0.754+0.002+0.3%€0.765€0.768€0.7540
€0.752-0.002-0.3%€0.763€0.773€0.7500
€0.754-0.005-0.7%€0.769€0.770€0.7250
€0.759-0.002-0.3%€0.759€0.759€0.7590
€0.761-0.007-0.9%€0.763€0.775€0.7540
€0.768+0.003+0.4%€0.769€0.775€0.7670
€0.765+0.014+1.9%€0.754€0.774€0.7510
€0.751-0.007-0.9%€0.769€0.778€0.7490
€0.758-0.013-1.7%€0.771€0.773€0.7550
€0.771-0.002-0.3%€0.779€0.779€0.7610
€0.773+0.016+2.1%€0.773€0.781€0.7390
Ticker
Frankfurt:82C
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Total Voting Rights

Nov 5, 2026

Closed €0.74 (+0.4%) on Nov 6, 2026

Director/PDMR Shareholding & RPT Update

Nov 4, 2026

Closed €0.742 (-0.5%) on Nov 4, 2026

Block Listing Cancellation and Interim Review

Oct 22, 2026

Closed €0.777 (+0.6%) on Oct 23, 2026

Result of General Meeting

Oct 21, 2026

Closed €0.757 (-3.1%) on Oct 21, 2026

Dividend Timetable

Apr 24, 2026

Closed €0.743 (+3.2%) on Apr 27, 2026

Director/PDMR Shareholding

Apr 21, 2026

Closed €0.644 (+2.1%) on Apr 21, 2026

Notice of 2026 Annual General Meeting

Apr 21, 2026

Closed €0.644 (+2.1%) on Apr 21, 2026

Exercise of Options, Director Dealing and TVR

Apr 17, 2026

Closed €0.631 (+0.6%) on Apr 20, 2026

All NIOX Group PLC news

NIOX Group PLC on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
19 in the last 12 months · 186 in all · newest Nov 9, 2026 · oldest 2014

Where NIOX Group PLC is listed

ListingExchangeCountryCurrency
LSE:NIOX · Home listingLSEUnited KingdomGBX
LS Exchange:A1XFBMLS ExchangeGermanyEUR
Lang & Schwarz:A1XFBMLang & SchwarzGermanyEUR
OTC:CSSPFOTCUnited StatesUSD
Frankfurt:82C · This pageFrankfurtGermanyEUR
Stuttgart:82CStuttgartGermanyEUR
Turquoise:NIOXLTurquoiseUnited KingdomGBX
Aquis:NIOXLAquisUnited KingdomGBX

Valuation

P/E 34.7× against a median of 33.0×: 5th lowest of 6 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
£227.1M GBP
P/E
34.7×
EV/sales
4.7×
EV/EBITDA
15.3×
Price/book
3.7×
Gross margin
60.8%
Operating margin
22.0%
Net margin
14.4%
Debt to equity
0.0×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NIOX Group PLC · LSE:NIOXUS$318.1MUS$297.0M34.7×4.7×15.3×3.7×14.4%0.0×n/a
COLTENE Holding AG · SIX:CLTNUS$336.6MUS$376.3M18.9×1.3×11.4×3.0×6.2%0.6×n/a
Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290US$330.8MUS$220.5M29.6×3.4×n/a1.0×17.2%0.1×n/a
ACRO Biomedical Co., Ltd. · TPEX:6748US$327.3MUS$299.5Mn/a258×n/a10.1×−216.1%0.0×n/a
Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041US$325.9MUS$288.8M44.4×1.2×9.7×1.1×3.0%0.1×n/a
Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653US$325.8MUS$231.2M34.2×4.8×n/a2.4×19.9%0.0×n/a
CapsoVision, Inc. · NASDAQ:CVUS$325.1MUS$304.1Mn/a21.9×n/a12.3×−210.1%0.0×0.88
Nanjing Medlander Medical Technology Co. Ltd. Class A · SSE:688273US$315.5MUS$208.7M33.0×3.6×n/a1.5×16.6%0.0×n/a
Supermax Corp. Bhd. · MYX:SUPERMXUS$312.4MUS$215.6Mn/a1.2×n/a0.3×−20.9%0.1×n/a
Chongqing Xishan Science and Technology Co., Ltd. Class A · SSE:688576US$301.5MUS$216.0Mn/a5.2×n/a1.2×−19.2%0.0×n/a
Sanara MedTech Inc. · NASDAQ:SMTIUS$299.1MUS$329.0Mn/a2.9×34.4×39.0×−2.7%6.1×0.49
Median of the othersUS$325.5MUS$260.0M33.0×3.5×11.4×2.0×0.2%0.1×0.69

Forecasts

Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
82.40 GBX · Analysts' mean
EPS, year to Dec 2026
0.029 · 4 analysts
Revenue, year to Dec 2026
50.48M · 5 analysts

Team and board

Officers

OfficerRole
Jonathan EmmsChief Executive Officer with immediate effect
Michael RollerChief Financial Officer
Rebecca Clayton-WherityCompany Secretary
James FischerSinger Capital Markets Nominated Adviser & Broker
James ToddSinger Capital Markets Nominated Adviser & Broker
Patrick WeaverSinger Capital Markets Nominated Adviser and Broker

Board

DirectorRole
Sarah Elizabeth DuncanDirector

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Oct 2, 2025+1.4%
Q2 2025Sep 30, 2025+0.8%
Quarter to Mar 31, 2025Apr 1, 2025−1.3%
Q2 2024Sep 24, 2024+3.6%
Q4 2022Mar 21, 2023 · Before open−2.2%
Q2 2022Sep 14, 2022 · Before open+5.6%
Q4 2021Mar 22, 2022 · Before open−7.0%
Quarter to Jun 30, 2021Sep 16, 2021 · Before open−0.7%
Quarter to Mar 31, 2021Jun 14, 2021−3.5%

Open Events

Financials

Annual, in GBP

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue48.7M41.8M36.8M31.3M27.9M23.9M34.6M
Cost of revenue19.1M11.6M10.3M9.10M8.90M7.60M9.10M
Gross profit29.6M30.2M26.5M22.2M19.0M16.3M25.5M
Research and development2.60M2.50M2.30M3.20M4.60M6.80M51.1M
Selling, general and administrative9.00M8.80M8.40M7.50M6.80M10.2M13.6M
Operating income10.7M7.70M4.60M1.80M-4.30M-17.3M-63.8M
Depreciation and amortization4.10M4.20M4.40M4.60M4.90M9.00M15.2M
EBITDA14.8M11.9M9.00M6.40M600.0K-8.30M-48.6M
Interest expense200.0K200.0K200.0K100.0K300.0K300.0K300.0K
Income before tax11.2M7.80M4.10M10.5M-2.10M-18.4M-27.6M
Income tax4.20M4.40M-5.40M-3.60M-4.40M8.40M-10.8M
Net income7.00M3.70M10.7M16.1M3.60M-33.5M-48.3M
Earnings per share, basic0.020.010.020.040.01-0.09-0.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents19.9M10.9M19.9M19.4M12.6M7.40M27.0M
Receivables6.00M6.20M8.80M7.90M4.50M18.3M14.8M
Inventory5.00M4.00M4.80M4.10M2.70M4.00M6.50M
Current assets30.9M21.1M33.5M31.4M19.8M29.7M48.3M
Goodwill4.80M4.30M4.60M4.70M4.80M5.30M4.80M
Total assets76.2M68.4M91.5M98.5M86.4M103.1M246.8M
Accounts payable2.20M1.60M1.10M500.0K500.0K5.20M9.10M
Current liabilities8.10M8.10M7.20M9.20M10.8M26.7M41.3M
Long-term debt109.9M
Total debt1.00M1.50M1.10M1.00M1.30M1.60M111.4M
Total liabilities8.60M8.90M7.70M16.6M19.6M37.0M162.0M
Shareholders' equity73.7M59.5M83.8M81.9M66.8M66.1M84.8M
Shares outstanding426.2M448.2M449.3M443.0M435.8M381.9M373.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations15.8M17.2M11.6M6.70M1.40M-23.9M-25.1M
Capital spending-200.0K-1.00M-300.0K-100.0K-200.0K-500.0K-300.0K
Free cash flow15.6M16.2M11.3M6.60M1.20M-24.4M-25.4M
Cash from investing-1.20M-1.00M-300.0K-100.0K-200.0K-500.0K-9.90M
Cash from financing-5.50M-25.1M-10.5M-500.0K4.10M4.30M21.9M
Dividends paid-5.00M-4.20M-10.5M
Share buybacks0-21.3M0
Change in cash9.00M-9.00M500.0K6.80M5.20M-19.6M-13.7M

Open Financials

Cap table

Built by 6ix from NIOX Group PLC’s releases

Common shares
405,273,133
Fully diluted
405,273,133

Fully diluted

LineShares
Common shares405,273,133

Share count over time

CountShares
Nov 22, 2026405,273,133

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
WisdomTree International SmallCap Dividend Fund408KUS$323KJun 30, 2026
WisdomTree Dynamic International SmallCap Equity Fund178KUS$141KJun 30, 2026

Big stakes

StakeStakeSharesDateFiling
AstraZeneca PLC16.31%66.1MOct 22, 2026TR-1 holding notification (FCA)
Artemis Investment Management LLP5.06%20.5MNov 6, 2026TR-1 holding notification (FCA)

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James FischerSinger Capital Markets Nominated Adviser & Broker · Since at least Oct 22, 2026
James ToddSinger Capital Markets Nominated Adviser & Broker · Since at least Oct 1, 2025
Jonathan EmmsChief Executive Officer with immediate effect · Since at least Jan 16, 2025
Michael RollerChief Financial Officer · Since at least Jan 16, 2025
Patrick WeaverSinger Capital Markets Nominated Adviser and Broker · Since at least Oct 22, 2026
Rebecca Clayton-WherityCompany Secretary · Since at least Apr 24, 2026
Sarah Elizabeth DuncanDirector · Since at least Jan 16, 2025

Open People

Log in to ask 6ix AI your own questions about NIOX Group PLC.